| Announce Date | 01/21/2026 |
| EPS Normalized Actual | $6.3 (Beat by $0.47) |
| EPS GAAP Actual | $6.3 (Beat by $0.47) |
| Revenue Actual | $1.6123B |
| Revenue Surprise | Beat by $1612.3M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 26 | 25.35 | 25.77465 | 26.53997 | 1 |
| Jan 2026 | 19.04667 | 34.61 | 18.39 | 19.75 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.84 | 5.84 | 1.6123B | 6.82% | 1612.3M |
| FQ3 2025 (Sep 2025) | 4.71 | 4.71 | 1.5395B | 6.24% | 1539.5M |
| FQ2 2025 (Jun 2025) | 4.48 | 4.48 | 1.5137B | 9.22% | 1513.7M |
| FQ1 2025 (Mar 2025) | 4.03 | 4.03 | 1.4499B | 6.88% | 1449.9M |
| FQ4 2024 (Dec 2024) | 4.25 | 4.25 | 1.5023B | 5.15% | 1502.3M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 1.4435B | 100% | 1443.5M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 1.3741B | 100% | 1374.1M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 1.3501B | -5.04% | 1350.1M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 7.54625 | -- | 7.48378 | 7.64147 | 4 |
| FQ3 2028 (Sep 2028) | 7.00773 | -- | 6.94971 | 7.09615 | 4 |
| FQ2 2028 (Jun 2028) | 6.71607 | -- | 6.66047 | 6.80081 | 4 |
| FQ1 2028 (Mar 2028) | 6.41184 | -- | 6.35876 | 6.49274 | 4 |
| FQ4 2027 (Dec 2027) | 6.93967 | -- | 6.86656 | 7.03127 | 2 |
| FQ3 2027 (Sep 2027) | 6.52957 | -- | 6.47209 | 6.612 | 1 |
| FQ2 2027 (Jun 2027) | 6.0278 | -- | 5.97473 | 6.1039 | 1 |
| FQ1 2027 (Mar 2027) | 5.78124 | -- | 5.73034 | 5.85423 | 1 |
| FQ4 2026 (Dec 2026) | 6.50587 | 10.23 | 6.42332 | 6.58041 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.84B | -- | 1.83B | 1.86B | 2 |
| FQ3 2028 (Sep 2028) | 1.79B | -- | 1.78B | 1.81B | 2 |
| FQ2 2028 (Jun 2028) | 1.74B | -- | 1.73B | 1.76B | 2 |
| FQ1 2028 (Mar 2028) | 1.69B | -- | 1.67B | 1.7B | 2 |
| FQ4 2027 (Dec 2027) | 1.76B | -- | 1.75B | 1.78B | 2 |
| FQ3 2027 (Sep 2027) | 1.67B | -- | 1.66B | 1.69B | 1 |
| FQ2 2027 (Jun 2027) | 1.61B | -- | 1.6B | 1.63B | 1 |
| FQ1 2027 (Mar 2027) | 1.56B | -- | 1.55B | 1.58B | 1 |
| FQ4 2026 (Dec 2026) | 1.72B | 6.04 | 1.7B | 1.73B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
0
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.84 | 5.84 | 100% | |
| FQ3 2025 (Sep 2025) | 4.71 | 4.71 | 100% | |
| FQ2 2025 (Jun 2025) | 4.48 | 4.48 | 100% | |
| FQ1 2025 (Mar 2025) | 4.03 | 4.03 | 100% | |
| FQ4 2024 (Dec 2024) | 4.25 | 4.25 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $1.61B | $1612.3M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $1.54B | $1539.5M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.51B | $1513.7M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.45B | $1449.9M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.5B | $1502.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.44B | $1443.5M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.37B | $1374.1M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.35B | $1350.1M | 100% |